SCHEMBL2912130

SCHEMBL2912130

COCCNC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.48
GSK3A P49840 3/20 0.48
CDK1 P06493 2/20 0.44
CCNB2 O95067 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
ALPL P05186 1/20 0.40
ALDH1A1 P00352 4/20 0.39
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CNR1 P21554 1/20 0.35
CYP2C19 P33261 1/20 0.35
JAK2 O60674 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2909865 0.92 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911606 0.92 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2909523 0.92 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910223 0.91 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2941039 0.90 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912808 0.90 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2909835 0.89 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912195 0.89 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910325 0.88 GSK3B (0.53) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2906785 0.88 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed